Welcome
Support Centre
08 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A pragmatic, single blind randomised controlled pilot study for professional kinesiology practice and back pain with initial feasibility study
ISRCTN ISRCTN76057921
ClinicalTrials.gov identifier
Public title A pragmatic, single blind randomised controlled pilot study for professional kinesiology practice and back pain with initial feasibility study
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Null hypothesis:
Kinesiology for back pain, as assessed by a reduction of 2.5 points on the Roland Morris Disability Scale after five weeks of treatment is not different from control.
Lay summary
Ethics approval Ethical approval was granted by South West Surrey Local Regional Ethics Committee on the 6th August 2004 (ref: 04/Q1909/22).
Study design A single blind, single centre, randomised controlled pilot study with initial feasibility study
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic and recurrent low back pain
Participants - inclusion criteria 1. 18 - 65 years, male and female
2. Chronic or recurrent non-specific low back pain (lower ribs to gluteal folds)
3. Previous episode of pain at least three months previously (constitutes a recurrent problem)
4. Current pain for the last three weeks (excludes short lived occurrence)
5. Roland Morris Disability scale score of greater than or equal to four (constitutes a clinical problem)
Participants - exclusion criteria 1. Under 18 years or over 65 (serious spinal pathology more likely)
2. Currently undergoing other treatment for back pain other than analgesics (other treatment may have carry-over effect) - six weeks washout required
3. Previous kinesiology (naivety required as a sham treatment is involved)
4. Serious spinal pathology or systemic illness (outside scope of study)
5. Psychosis or alcohol abuse (completion of forms, safety of practitioner)
6. Disability of limbs, inability to lie on or get on and off an examination couch (for purpose of muscle testing)
7. Weigh more than 15 stone (safety limit of examination table)
8. Litigation pending due to back pain or receiving disability allowance due to back pain (potential treatment resistance until monies received or stopped)
9. Previous spinal operation or waiting for same (outcome likely to be different). Facet joint injections are accepted because the spinal anatomy remains the same.
Anticipated start date 01/09/2007
Anticipated end date 31/01/2009
Status of trial Completed
Patient information material
Target number of participants 150
Interventions 1. Real kinesiolology: five treatments - once a week for five weeks
2. Sham kinesiology: five treatments - once a week for five weeks
3. Waiting control: six-week wait then re-randomised to either real or sham kinesiology - five treatments, once a week for five weeks
Primary outcome measure(s) Back pain disability measured on the Roland Morris Disability Scale, a 24 item tick questionnaire where a score of at least four points indicates a clinical problem suficient to measure change and a reduction of 2.5 after treatment indicates clinical change. Data collected at baseline, end of treatment and follow up.
Secondary outcome measure(s) 1. 36-item short form health survey (SF-36): a global quality of life scale - 11 questions measuring physical function, role limitation, mental health, vitality, pain and general health, measured at baseline, end of treatment and follow up
2. Visual Analogue Scale (VAS) for pain (0 - 10) (0 = no pain, 10 = worst imaginable pain), measured at baseline, end of treatment and follow up
3. Patient Enablement Instrument (a measure of patient enablement): six questions asking how the patient feels about coping with life after the consultation - scored on a four-point scale, measured at end of treatment
4. Consultation and Relational Empathy (CARE) (a measure of empathy): 11 questions scored on a six-point scale - how did the patient feel the practitioner was at making them feel at ease, etc., measured at end of treatment
5. Measure Yourself Medical Outcome Profile (MYMOP) (a patient rating of their chosen symptoms) comprises four items, scored by the patient on a seven point scale. The first two items are for symptoms that the patient decides are most important to them and the other items relate to daily activities and general well-being, measured at baseline, end of treatment and follow up
6. Holistic Complementary and Alternative Medicine Questionnaire (HCAMQ) (a measure of beliefs about complementary medicine): 17 questions asking about the patients beliefs about health and treatment, measured at baseline, end of treatment and follow up
7. Credibility/expectancy questionnaire: six questions asking how much the patient believes the treatment will help their condition, measured at end of treatment
Sources of funding Investigator initiated and funded (UK)
Trial website
Publications
Contact name Prof  George  Lewith
  Address University of Southampton
Aldermoor Health Centre
Aldermoor Close
  City/town Southampton
  Zip/Postcode SO16 5ST
  Country United Kingdom
Sponsor The University of Southampton (UK)
  Address Aldermoor Health Centre
Aldermoor Close
  City/town Southampton
  Zip/Postcode SO16 5ST
  Country United Kingdom
  Email S.S.Hall@soton.ac.uk
  Sponsor website: http://www.soton.ac.uk/
Date applied 19/11/2007
Last edited 10/04/2008
Date ISRCTN assigned 10/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central